Anupam Rasayan Q3FY26 profit rises 12% on sales

Key takeaway from the Q3 update

Anupam Rasayan India reported a year-on-year increase in consolidated profit for the third quarter of FY26, helped by higher revenue in the October-December period. The company disclosed that consolidated net profit for Q3FY26 rose about 12% to nearly ₹61 crore. Total revenue for the quarter rose 31.35% to ₹512.44 crore, compared with ₹390.14 crore in the year-ago quarter. Alongside the results, the company announced an agreement to acquire US-based Jayhawk Fine Chemicals Corporation, a strategic move aimed at expanding its international footprint.

What the company reported for Q3FY26

In its regulatory filing, Anupam Rasayan said consolidated net profit for the quarter increased to about ₹61 crore from ₹54.21 crore in Q3FY25. Another set of quarter financials in the provided data shows profit after tax (PAT) at ₹60.59 crore, reflecting a 6.0% quarter-on-quarter (QoQ) increase and an 11.8% year-on-year (YoY) increase. The same dataset indicates profit before tax (PBT) of ₹59.95 crore for Q3FY26. Revenue growth was the headline driver, with total revenue rising to ₹512.44 crore from ₹390.14 crore in Q3FY25.

Profitability mix: PBT down QoQ, PAT up

The quarter showed an unusual split between PBT and PAT trends. PBT in Q3FY26 was reported at ₹59.95 crore, down 20.6% from ₹75.54 crore in Q2FY26. But compared with Q3FY25 PBT of ₹59.50 crore, it was marginally higher by 0.8%. The tax line was a key swing factor: tax expense was reported as negative at -₹0.64 crore in Q3FY26, compared with ₹18.38 crore in Q2FY26 and ₹5.29 crore in Q3FY25. As a result, PAT rose to ₹60.59 crore in Q3FY26 even though PBT declined sequentially.

Revenue growth points to stronger quarter-on-quarter demand

The company’s consolidated revenue for Q3FY26 came in at ₹512.44 crore, up 31.35% YoY from ₹390.14 crore in Q3FY25. The article context attributes the profit increase to higher sales, without adding segment-level breakups. The combination of revenue growth and the tax swing explains why net profit increased even as PBT fell QoQ. Investors generally track whether profit growth is driven by operating performance or below-the-line items, and in this quarter the tax line clearly influenced the reported PAT.

Strategic development: Jayhawk Fine Chemicals acquisition

Anupam Rasayan also announced an agreement to acquire US-based Jayhawk Fine Chemicals Corporation. The deal size was reported at $150 million. The acquisition is positioned as a step to strengthen Anupam’s global presence, expand custom synthesis capabilities, and add a US manufacturing presence. The context also links the transaction to enhancing the company’s global CDMO (contract development and manufacturing) capabilities and its polymer portfolio. The provided text notes that the stock surged following the acquisition announcement, although it does not specify the exact price move.

Snapshot table: Q3FY26 versus recent comparison points

Additional context from recent quarters and full-year FY25

The supplied data also includes figures from a different quarter update: Q2FY26 total revenue was reported at ₹739.2 crore (₹7,392 million), compared with ₹295.9 crore (₹2,959 million) in Q2FY25, implying a 149% YoY increase for that quarter. Q2FY26 EBITDA (including other income) was reported at ₹143.6 crore (₹1,436 million) versus ₹82.4 crore (₹824 million) in Q2FY25, translating into an EBITDA margin of 19%. Q2FY26 PAT was reported at ₹57.2 crore (₹572 million) versus ₹30.6 crore (₹306 million) in Q2FY25, up 87% YoY.

On a full-year basis for FY25, the company’s consolidated net profit was reported to have fallen 27.41% to ₹93.35 crore, while revenue declined 2.58% to ₹1,436.97 crore versus FY24. This backdrop is relevant because it shows that FY26 quarterly performance is being assessed against a mixed recent trend in profitability and revenue growth. Separately, the provided text also mentions Q4 FY25 EBITDA (including other income) of ₹150 crore versus ₹104.7 crore in Q4 FY24, a 43% increase and a 30% EBITDA margin for that quarter.

Market impact: what investors are likely to track

From the market’s perspective, the Q3FY26 update had two clear pillars: a profit increase on the back of higher revenue, and the Jayhawk acquisition announcement. On numbers alone, the quarter delivered 31.35% YoY revenue growth and about 12% YoY net profit growth, based on the regulatory filing. But the detailed profitability bridge shows PBT declined QoQ while PAT increased, largely due to the negative tax expense in Q3FY26. For investors, this makes it important to differentiate operating performance from one-off or timing effects in the tax line, using subsequent filings and management commentary.

The acquisition component matters because it introduces execution considerations such as integration and the expected benefits of a US manufacturing presence. The company has described the deal as a way to strengthen global CDMO capabilities and broaden its portfolio. Since the article text does not provide synergy estimates or timelines, the only confirmed market signal in the supplied content is that the stock moved up after the acquisition announcement.

Why the Q3FY26 print matters

The Q3FY26 results show that Anupam Rasayan delivered a solid YoY improvement in sales and net profit during the October-December quarter. At the same time, the quarter highlights how quickly headline profit can be influenced by shifts in tax expense, as seen in the move to -₹0.64 crore in Q3FY26. The Jayhawk acquisition announcement adds a strategic layer to the earnings narrative, with the company explicitly linking the deal to international manufacturing presence and custom synthesis scale.

Conclusion

Anupam Rasayan’s Q3FY26 performance combined 31.35% YoY revenue growth with about a 12% YoY rise in consolidated net profit to around ₹61 crore. The quarter also stood out for a negative tax expense that supported PAT despite a QoQ fall in PBT. The other major development was the $150 million agreement to acquire Jayhawk Fine Chemicals, which the company said would strengthen its US presence and global CDMO capabilities. Investors will now watch for further details from the company on the acquisition process and for upcoming quarters to clarify how much of profitability is driven by operating trends versus tax-line movements.